OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
Ming Zhao, Timothy P. DiPeri, Maria Gabriela Raso, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Ming Zhao, Timothy P. DiPeri, Maria Gabriela Raso, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2089-2108
Closed Access | Times Cited: 20
Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2089-2108
Closed Access | Times Cited: 20
ImmunoPET imaging of Trop2 in patients with solid tumours
Wei Huang, You Zhang, Min Cao, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 5, pp. 1143-1161
Open Access | Times Cited: 15
Wei Huang, You Zhang, Min Cao, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 5, pp. 1143-1161
Open Access | Times Cited: 15
Progress and Innovative Combination Therapies in Trop-2-Targeted ADCs
Yizhi Jiang, Haiting Zhou, Junxia Liu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 652-652
Open Access | Times Cited: 8
Yizhi Jiang, Haiting Zhou, Junxia Liu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 652-652
Open Access | Times Cited: 8
Role of ZEB1 in immune response, inflammation and membrane remodeling during neoplasia
Alicia Maria Reveles-Espinoza, Richard Roque, Alba Adriana Vallejo‐Cardona
Exploration of Immunology (2025) Vol. 5
Open Access
Alicia Maria Reveles-Espinoza, Richard Roque, Alba Adriana Vallejo‐Cardona
Exploration of Immunology (2025) Vol. 5
Open Access
Novel treatment approaches utilizing antibody-drug conjugates in breast cancer
Andrew A. Davis, Jennifer Hesse, Patrícia M. R. Pereira, et al.
npj Breast Cancer (2025) Vol. 11, Iss. 1
Open Access
Andrew A. Davis, Jennifer Hesse, Patrícia M. R. Pereira, et al.
npj Breast Cancer (2025) Vol. 11, Iss. 1
Open Access
DNA demethylation and tri-methylation of H3K4 at the TACSTD2 promoter are complementary players for TROP2 regulation in colorectal cancer cells
Andrew G. Gehring, K Huebner, Harsha Rani, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Andrew G. Gehring, K Huebner, Harsha Rani, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities
Alok Kafle, Sutas Suttiprapa, Mubarak Muhammad, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 9, pp. e0012477-e0012477
Open Access | Times Cited: 1
Alok Kafle, Sutas Suttiprapa, Mubarak Muhammad, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 9, pp. e0012477-e0012477
Open Access | Times Cited: 1
Anti-tumor activity and biomarker analysis for TROP2-antibody drug conjugate Datopotamab deruxtecan in patient-derived breast cancer xenograft models
Funda Meric‐Bernstam, Erkan Yuca, Kurt W. Evans, et al.
Clinical Cancer Research (2024) Vol. 31, Iss. 3, pp. 573-587
Open Access | Times Cited: 1
Funda Meric‐Bernstam, Erkan Yuca, Kurt W. Evans, et al.
Clinical Cancer Research (2024) Vol. 31, Iss. 3, pp. 573-587
Open Access | Times Cited: 1
Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy
Rositsa Mihaylova, Denitsa Momekova, Viktoria Elincheva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1701-1701
Open Access | Times Cited: 1
Rositsa Mihaylova, Denitsa Momekova, Viktoria Elincheva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1701-1701
Open Access | Times Cited: 1
Research progress of the SLFN family in malignant tumors
Jiale Yu, Zhijuan Guo, Junyi Zhang
Frontiers in Oncology (2024) Vol. 14
Open Access
Jiale Yu, Zhijuan Guo, Junyi Zhang
Frontiers in Oncology (2024) Vol. 14
Open Access
